These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 15729079)
1. Prevention of intraperitoneal adhesions and abscesses by polysaccharides isolated from Phellinus spp in a rat peritonitis model. Bae JS; Ahn SJ; Yim H; Jang KH; Jin HK Ann Surg; 2005 Mar; 241(3):534-40. PubMed ID: 15729079 [TBL] [Abstract][Full Text] [Related]
2. The effect of polysaccharides and carboxymethylcellulose combination to prevent intraperitoneal adhesion and abscess formation in a rat peritonitis model. Bae JS; Jin HK; Jang KH J Vet Med Sci; 2004 Oct; 66(10):1205-11. PubMed ID: 15528850 [TBL] [Abstract][Full Text] [Related]
3. Comparison of intraperitoneal anti-adhesive polysaccharides derived from Phellinus mushrooms in a rat peritonitis model. Bae JS; Jang KH; Jin HK World J Gastroenterol; 2005 Feb; 11(6):810-6. PubMed ID: 15682472 [TBL] [Abstract][Full Text] [Related]
4. Polyanionic polysaccharides reduce intra-abdominal adhesion and abscess formation in a rat peritonitis model. Reijnen MM; Skrabut EM; Postma VA; Burns JW; van Goor H J Surg Res; 2001 Dec; 101(2):248-53. PubMed ID: 11735283 [TBL] [Abstract][Full Text] [Related]
5. Prevention of intra-abdominal abscesses and adhesions using a hyaluronic acid solution in a rat peritonitis model. Reijnen MM; Meis JF; Postma VA; van Goor H Arch Surg; 1999 Sep; 134(9):997-1001. PubMed ID: 10487596 [TBL] [Abstract][Full Text] [Related]
6. Effect of intraperitoneal antiadhesive fluids in a rat peritonitis model. Müller SA; Treutner KH; Haase G; Kinzel S; Tietze L; Schumpelick V Arch Surg; 2003 Mar; 138(3):286-90. PubMed ID: 12611576 [TBL] [Abstract][Full Text] [Related]
7. Role of a hyaluronate-based membrane in the prevention of peritonitis-induced adhesions. Ghellai AM; Stucchi AF; Lynch DJ; Skinner KC; Colt MJ; Becker JM J Gastrointest Surg; 2000; 4(3):310-5. PubMed ID: 10769095 [TBL] [Abstract][Full Text] [Related]
8. Both tissue-type plasminogen activator and urokinase prevent intraabdominal abscess formation after surgical treatment of peritonitis in the rat. Buyne OR; van Goor H; Bleichrodt RP; Verweij PE; Hendriks T Surgery; 2008 Jul; 144(1):66-73. PubMed ID: 18571586 [TBL] [Abstract][Full Text] [Related]
9. Prevention of intraperitoneal adhesion formation using beta-glucan after ileocolic anastomosis in a rat bacterial peritonitis model. Bedirli A; Gokahmetoglu S; Sakrak O; Ersoz N; Ayangil D; Esin H Am J Surg; 2003 Apr; 185(4):339-43. PubMed ID: 12657386 [TBL] [Abstract][Full Text] [Related]
10. Auto-cross-linked hyaluronic acid gel does not reduce intra-abdominal adhesions or abscess formation in a rat model of peritonitis. Sikkink CJ; de Man B; Bleichrodt RP; van Goor H J Surg Res; 2006 Dec; 136(2):255-9. PubMed ID: 17059836 [TBL] [Abstract][Full Text] [Related]
11. Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis. van Goor H; de Graaf JS; Kooi K; Sluiter WJ; Bom VJ; van der Meer J; Bleichrodt RP J Am Coll Surg; 1994 Oct; 179(4):407-11. PubMed ID: 7921389 [TBL] [Abstract][Full Text] [Related]
12. Keratinocyte Growth Factor Combined with a Sodium Hyaluronate Gel Inhibits Postoperative Intra-Abdominal Adhesions. Wei G; Zhou C; Wang G; Fan L; Wang K; Li X Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669222 [TBL] [Abstract][Full Text] [Related]
13. Polyvinyl alcohol hydrogel decreases formation of adhesions in a rat model of peritonitis. Deerenberg EB; Mulder IM; Ditzel M; Slieker JC; Bemelman WA; Jeekel J; Lange JF Surg Infect (Larchmt); 2012 Oct; 13(5):321-5. PubMed ID: 22789109 [TBL] [Abstract][Full Text] [Related]
14. The efficacy of a hyaluronate-carboxymethylcellulose bioresorbable membrane that reduces postoperative adhesions is increased by the intra-operative co-administration of a neurokinin 1 receptor antagonist in a rat model. Lim R; Stucchi AF; Morrill JM; Reed KL; Lynch R; Becker JM Surgery; 2010 Nov; 148(5):991-9. PubMed ID: 20338610 [TBL] [Abstract][Full Text] [Related]
15. Tissue-type plasminogen activator prevents formation of intra-abdominal abscesses after surgical treatment of secondary peritonitis in a rat model. Buyne OR; Bleichrodt RP; van Goor H; Verweij PE; Hendriks T Int J Colorectal Dis; 2007 Jul; 22(7):819-25. PubMed ID: 17089129 [TBL] [Abstract][Full Text] [Related]
16. Effects of seprafilm on peritoneal fibrinolytic system. Tarhan OR; Eroglu A; Cetin R; Y Nce A; Bulbul M; Altuntas YR ANZ J Surg; 2005 Aug; 75(8):690-2. PubMed ID: 16076334 [TBL] [Abstract][Full Text] [Related]
18. [Inhibition of abdominal abscess formation in rat: mortality by sepsis]. Rodrigues FH; Carneiro BG; Rocha RF; Petroianu A Arq Gastroenterol; 2005; 42(1):50-4. PubMed ID: 15976911 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of human recombinant tissue-type plasminogen activator, administered intra-abdominally, in a rat peritonitis model. van Goor H; Bom VJ; van der Meer J; Sluiter WJ; Geerards S; van der Schaaf W; de Graaf JS; Bleichrodt RP Eur Surg Res; 1996; 28(4):287-94. PubMed ID: 8813653 [TBL] [Abstract][Full Text] [Related]
20. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis. Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]